Скачать или смотреть Samsung Medical Center Develops AI to Predict Lung Cancer Recurrence Risk

Learn how Samsung Medical Center's latest AI breakthrough, RADAR CARE, is transforming lung cancer treatment by predicting recurrence risk for non-small cell lung cancer (NSCLC) patients up to a year in advance.

Discover how RADAR CARE combines clinical data, pathology results, CT scans, and patient histories to assign risk scores—low, intermediate, or high—that can guide personalized treatment. Hear about the study involving 14,177 early-stage NSCLC patients, which found high-risk individuals have a 10% recurrence rate within a year, compared to just 1% in the low-risk group.

Find out why this innovation matters for early lung cancer diagnosis and how it may revolutionize post-surgical care and follow-up, benefiting both patients and clinicians. Get insights into the global AI trend in cancer prognosis, including similar advances in liver cancer detection and genomic testing.

Keywords: AI for lung cancer, NSCLC recurrence prediction, RADAR CARE, personalized oncology, Samsung Medical Center, cancer risk scoring, medical AI breakthroughs.